Navigation Links
Money Matters When Choosing an Infertility Treatment

If advice is cheap, ART — assisted reproductive technology — is not, and the difference in cost has a significant effect on the treatments pursued by infertile couples in the United States.//

Not surprisingly, an infertile couple’s income makes a difference in whether they pursue an expensive technology such as in vitro fertilization, but income and insurance coverage also have a strong impact on whether they choose less costly options such as medication and surgery, according to a new study in the journal Health Services Research.

Income and insurance did not affect whether couples sought out a doctor’s advice, the lowest-cost and least effective type of treatment, say J. Farley Ordovensky Staniec, Ph.D., of the University of the Pacific in Stockton, Calif., and Natalie Webb, Ph.D., of the Naval Postgraduate School in Monterey.

“For the 11 percent of women of childbearing age facing fertility problems and considering their options, money does matter,” Staniec said.

The researchers looked at 1995 survey data from nearly 11,000 women, 1,210 of whom had fertility problems or were part of a couple with fertility problems. Of the 1,091 women ages 22 and older with problems, nearly six percent sought advice only from their doctors, 7 percent had fertility tests but no other treatment, 11 percent used drugs to induce ovulation but no other treatments, 3 percent had surgery and nearly 6 percent pursued treatments such as in vitro fertilization and related procedures.

By comparing these treatment options with information about the women’s income and insurance, Staniec and Webb found that low-income women were only 65 percent as likely as their richer counterparts to seek help for infertility.

However, treatment costs influenced treatment choices for most women in the study, the researchers concluded. “For options beyond ‘advice only,’ income plays a significant role in all but the choice to use ovulatio
'"/>




Page: 1 2

Related medicine news :

1. B Vitamin Supplementatoin Saves Money and Lives
2. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
3. Finance Problems Result In Money Sickness Syndrome
4. Losing Sleep over Money or Money over Sleep? Sleep over It!
5. The Long Wait Continues In the Health Care Service despite the Money Factor
6. NHS Forced to Borrow Money at Rates of 10 percent
7. Money Matter Even To the Brain
8. Health Promotion Drives Waste Money, Claim Nurses
9. Failure to Keep Appointments causing Loss of Money
10. Money Allocated for Child Welfare Programme In Kashmir
11. Money Spent On Cancer worth Every Penny

Post Your Comments:
(Date:12/1/2009)...SHENZHEN, China, Dec. 1 /PRNewswire-Asia-FirstCall...PD ) ("Nepstar" or "the Company"), the largest ret...f directly operated stores,today announced its un...ded,September 30, 2009. ,, Financial High...ted a voting rights assignment agreement,which as...
(Date:12/1/2009)...ltrasound with elastography can help differentiate...ording to a study presented today at the annual me... (RSNA). , "High-frequency ultrasound with elast...y of skin cancer diagnosis," said lead author Elio... of Radiology at the University of Maryland School...
(Date:12/1/2009)... as a child could lead to early degeneration in th...he annual meeting of the Radiological Society of N...to show an association between increased body mass...said the study,s lead author, Judah G. Burns, M.D....ren,s Hospital at Montefiore in New York City. ,...
(Date:11/30/2009)...ast Coast Fertility is attempting to dispel the no...ments and send patients home pregnant with multipl...e patient, their priority is health and safety. I...e births can put on a country’s healthcare s...ber 30, 2009 -- Many patients and doctors in the U...
(Date:11/30/2009)... A study using functional magnetic...on revealed that adults who were exposed to lead a...ts were presented today at the annual meeting of t..., "What we have found is that no region of the ...y,s lead author, Kim Cecil, Ph.D., imaging scienti...
Breaking Medicine News(10 mins):Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 2Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 3Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 4Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 5Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 6Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 7Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 8Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 9Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 10Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 11Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 12Health News:China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009 13Health News:Special ultrasound accurately identifies skin cancer 2Health News:Overweight children may develop back pain and spinal abnormalities 2Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 2Health News:East Coast Fertility Aims to Build Families One Baby at a Time by Applying Single Embryo Transfers to Donor Egg Program 3Health News:Childhood Lead Exposure Causes Permanent Brain Damage 2Health News:Childhood Lead Exposure Causes Permanent Brain Damage 3
...e Online Charity Auction of Designer, Handbags f...e Ovarian Cancer Research...ding premium,appliance brand, and Kelly Ripa have ...t ovarian cancer. The bags,were featured in "Kelly...
...eatly reduced if parents quit, LONDON, May 28 If...ows that a child,s odds of daily smoking are,reduc...h parents continue,to smoke. And if both parents w...ldren who start smoking.(2), As global leaders in...
...eive $10,000 scholarships to help with,escalating ...fort to promote,diversity and help with the rapidl...edical Association (AMA) Foundation has presented ...ise for the future,among first- or second-year med...
...s of $35 Cost Per Metric Ton of CO2 Indica...PITTSBURGH, May 28 As recent judicial, political ...ve the United States toward a,mandatory price for ...fects of establishing such a cost. The research,pu...
... and PainSmart Infusion Pumps Undergo,Immediate Te...tion,Overinfusion, PLYMOUTH MEETING, Pa., May 28 ...ndent, nonprofit organization that,researches the ...esources_pages_default.aspx, ,recommending immedia...
... remarks by,Attorney General Michael B. Mukasey on...care fraud nationwide:, Thank you, and good after...e importance of the job that the Justice Departmen...or your hard,work., Our nation,s health care syst...
Other Medicine News:Health News:Coveting the Latest Clutch? Bid on a Bag and Help Fight Ovarian Cancer 2Health News:Parents: Quit Smoking and Your Children Are Less Likely to Smoke 2Health News:Parents: Quit Smoking and Your Children Are Less Likely to Smoke 3Health News:Parents: Quit Smoking and Your Children Are Less Likely to Smoke 4Health News:AMA Foundation Names Minority Scholars Award Recipients 2Health News:Establishing a Price for Carbon Emissions in the U.S. Would Spur Immediate Reductions in Energy Consumption and More Efficient Use of Power Generators, Study by Carnegie Mellon Researchers Shows 2Health News:Establishing a Price for Carbon Emissions in the U.S. Would Spur Immediate Reductions in Energy Consumption and More Efficient Use of Power Generators, Study by Carnegie Mellon Researchers Shows 3Health News:ECRI Institute Issues Priority Alert About Two Infusion Pumps 2Health News:Prepared Remarks of Attorney General Michael B. Mukasey on the Justice Department's Efforts to Combat Healthcare Fraud Nationwide 2Health News:Prepared Remarks of Attorney General Michael B. Mukasey on the Justice Department's Efforts to Combat Healthcare Fraud Nationwide 3
(Date:12/1/2009)... An expert from PAREXEL I...ng global biopharmaceutical services provider, wil... to drug development in Asia at the Partnerships i...eld December 1-3, 2009 at the Intercontinental Hot...rence, which is focused on maximizing efficiency a...
(Date:11/30/2009)...ewswire-FirstCall/ -- DATATRAK International, Inc....focused on global eClinical solutions for the clin...rma Focus AG (PFC) has joined its CRO Connect Prog... DATATRAK,s CRO partner training and offer its cli... addition, PFC will also have access to Partner pr...
(Date:11/30/2009)...30 Covance Inc. (NYSE: ... Piper Jaffray 21st Annual Health Care Conference ... Investors may access a live webcast of the presen... and download any necessary software, please log o...rs in Princeton, New Jersey, is one of the world,s...
Breaking Medicine Technology:PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 3PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 4PFC Pharma Joins DATATRAK's CRO Connect Program 2PFC Pharma Joins DATATRAK's CRO Connect Program 3PFC Pharma Joins DATATRAK's CRO Connect Program 4Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 1Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 2Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 3Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 4Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis 12392 5Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 1Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 2Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 3Physicians Join With National Healthcare Leaders to Explore New Ways to Enhance Geriatric Care in America 47493 1Physicians Join With National Healthcare Leaders to Explore New Ways to Enhance Geriatric Care in America 47493 2Physicians Join With National Healthcare Leaders to Explore New Ways to Enhance Geriatric Care in America 47493 3
...nd Achieves All Key Endpoints for Both Efficacy an...ire-FirstCall/ --,Indevus Pharmaceuticals, Inc. to...rmacokinetic trial for NEBIDO (testosterone,undeca...rapy under,development for the treatment of male h...Schering Pharma AG, Germany. The data,from the rec...
...en(TM) is evaluating zonisamide SR as a novel comp...DIEGO, June 07, 2007 /PRNewswire-FirstCall/ -- Ore... company focused on the,treatment of central nervo...ty, today announced results from a Phase I trial e..., proprietary,sustained-release (SR) formulation ...
Other Medicine Technology:Indevus Reports Positive Data From Phase III NEBIDO Trial 2Indevus Reports Positive Data From Phase III NEBIDO Trial 3Indevus Reports Positive Data From Phase III NEBIDO Trial 4Indevus Reports Positive Data From Phase III NEBIDO Trial 5Indevus Reports Positive Data From Phase III NEBIDO Trial 6OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 2OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 3OREXIGEN Therapeutics Announces Sustained-Release Formulation of,Zonisamide Shows Improved Tolerability When Compared to Immediate,Release Formulation 4
Wright-Giemsa Stain Solutions
...s Statim Stain is ideal for stat, routine or back-...rs and bone marrow. Our unique manufacturing proce...h yield excellent color intensity and morphologica... involved in the Wright's staining procedure and i...
Tetrachrome Blood Stain
Buffered Wright-Giemsa Stain
Medicine Products: